BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 35012825)

  • 1. Pityriasis Rosea-like eruptions following COVID-19 mRNA-1273 vaccination: A case report and literature review.
    Wang CS; Chen HH; Liu SH
    J Formos Med Assoc; 2022 May; 121(5):1003-1007. PubMed ID: 35012825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pityriasis rosea, pityriasis rosea-like eruptions, and herpes zoster in the setting of COVID-19 and COVID-19 vaccination.
    Drago F; Broccolo F; Ciccarese G
    Clin Dermatol; 2022; 40(5):586-590. PubMed ID: 35093476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maculopapular eruptions following COVID-19 vaccination: Pityriasis rosea or pityriasis rosea-like eruptions?
    Ciccarese G; Mastrolonardo M; Serviddio G; Drago F
    J Cosmet Dermatol; 2023 Sep; 22(9):2380-2381. PubMed ID: 37382032
    [No Abstract]   [Full Text] [Related]  

  • 4. Pityriasis Rosea after COVID-19 Infection.
    Prtajin M; Ljubojević Hadžavdić S
    Acta Dermatovenerol Croat; 2022 Dec; 30(4):265-266. PubMed ID: 36919396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reply to "the significance of investigating clinical, histopathologic and virological features in pityriasis rosea and pityriasis rosea-like eruptions following COVID-19 vaccinations" by Ciccarese G. et al.
    Martora F; Picone V; Battista T; Fabbrocini G; Marasca C
    Dermatol Ther; 2022 Aug; 35(8):e15602. PubMed ID: 35622446
    [No Abstract]   [Full Text] [Related]  

  • 6. Manifestation of pityriasis rosea and pityriasis rosea-like eruptions after Covid-19 vaccine: A systematic review.
    Khan I; Elsanousi AA; Shareef AM; Tebha SS; Arif A; Gul S
    Immun Inflamm Dis; 2023 Apr; 11(4):e804. PubMed ID: 37102660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of investigating clinical, histopathologic and virological features in pityriasis rosea and pityriasis rosea-like eruptions following COVID-19 vaccinations.
    Ciccarese G; Parodi A; Drago F
    Dermatol Ther; 2022 Aug; 35(8):e15601. PubMed ID: 35622411
    [No Abstract]   [Full Text] [Related]  

  • 8. Pityriasis Rosea Associated With COVID-19 Vaccination: A Common Rash Following Administration of a Novel Vaccine.
    Valk B; Bender B
    Cutis; 2021 Dec; 108(6):317-318. PubMed ID: 35167784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pityriasis rosea-like rash after messenger RNA COVID-19 vaccination: A case report and review of the literature.
    Buckley JE; Landis LN; Rapini RP
    JAAD Int; 2022 Jun; 7():164-168. PubMed ID: 35156062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review of Pityriasis Rosea in Relation to SARS-CoV-2/COVID-19 Infection and Vaccination.
    Wong N; Cascardo CA; Mansour M; Qian V; Potts GA
    Cureus; 2023 May; 15(5):e38772. PubMed ID: 37303403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine.
    Cyrenne BM; Al-Mohammedi F; DeKoven JG; Alhusayen R
    J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):e546-e548. PubMed ID: 33982814
    [No Abstract]   [Full Text] [Related]  

  • 12. Pityriasis rosea in a hepatitis B-positive patient treated with pegylated interferon α2a: report of a case and review of the literature.
    Drago F; Javor S; Bruzzone L; Drago F; Parodi A; Picciotto A
    Dermatology; 2014; 228(1):10-3. PubMed ID: 24335203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent pityriasis rosea: an unusual form of pityriasis rosea with persistent active HHV-6 and HHV-7 infection.
    Drago F; Broccolo F; Ciccarese G; Rebora A; Parodi A
    Dermatology; 2015; 230(1):23-6. PubMed ID: 25612842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case Report: Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination.
    Leerunyakul K; Pakornphadungsit K; Suchonwanit P
    Front Med (Lausanne); 2021; 8():752443. PubMed ID: 34557507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pityriasis Rosea Shortly After mRNA-1273 COVID-19 Vaccination.
    Shin SH; Hong JK; Hong SA; Li K; Yoo KH
    Int J Infect Dis; 2022 Jan; 114():88-89. PubMed ID: 34740803
    [No Abstract]   [Full Text] [Related]  

  • 16. Pityriasis Rosea: A Comprehensive Classification.
    Drago F; Ciccarese G; Rebora A; Broccolo F; Parodi A
    Dermatology; 2016; 232(4):431-7. PubMed ID: 27096928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pityriasis Rosea Following Pfizer-BioNTech Vaccination in an Adolescent Girl.
    Bin Rubaian NF; Almuhaidib SR; Aljarri SA; Alamri AS
    Cureus; 2022 Jul; 14(7):e27108. PubMed ID: 36004038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pityriasis rosea after mRNA COVID-19 vaccination.
    Abdullah L; Hasbani D; Kurban M; Abbas O
    Int J Dermatol; 2021 Sep; 60(9):1150-1151. PubMed ID: 34110010
    [No Abstract]   [Full Text] [Related]  

  • 19. Pityriasis rosea following influenza (H1N1) vaccination.
    Chen JF; Chiang CP; Chen YF; Wang WM
    J Chin Med Assoc; 2011 Jun; 74(6):280-2. PubMed ID: 21621174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HHV 6-7 reactivation causing Pityriasis Rosea and labyrinthitis: A case report.
    El-Hussein M; El-Tawil C; Nakhle R; Souaiby N
    Am J Emerg Med; 2020 Sep; 38(9):1969.e1-1969.e3. PubMed ID: 32553563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.